Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CPH/EMBLA stock hub

CPH/EMBLA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/EMBLAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.6B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/EMBLA

In the news

Latest news · CPH/EMBLA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.8

P25 14.6P50 19.5P75 24.2

Trailing P/E20.8

P25 11.8P50 20.8P75 32.9

ROE10.1

P25 -4.6P50 11.3P75 24.2

ROIC7.2

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/EMBLA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Iceland
Country code	DK
Employees	4,500
Employees Change	305%
Employees Change Percent	7.27
Enterprise value	DKK 14.6B
Exchange	Copenhagen Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	IS0000000040
Last refreshed	2026-05-10
Market cap	DKK 11.6B
Price	DKK 27.2
Price currency	DKK
Rev Per Employee	1,380,411.23x
Sector	Healthcare
Sic	3842
Symbol	cph/EMBLA
Website	https://www.emblamedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.78%
EV Earnings	26.33x
EV/EBIT	17.12x
EV/EBITDA	12.09x
EV/FCF	20.86x
EV/Sales	2.35x
FCF yield	6.04%
Forward P/E	18.76x
P/B ratio	1.98x
P/E ratio	20.81x
P/S ratio	1.87x
PE Ratio10 Y	59.55x
PE Ratio3 Y	29.96x
PE Ratio5 Y	36.22x
PEG ratio	1.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.09%
EBITDA Margin	15.68%
FCF margin	11.28%
Gross margin	61.97%
Gross Profit	DKK 3.8B
Gross Profit Growth	9.56%
Gross Profit Growth Q	11.96%
Gross Profit Growth3 Y	9.91%
Gross Profit Growth5 Y	8.33%
Net Income	DKK 555.1M
Net Income Growth	18.64%
Net Income Growth Q	18.9%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Net Income Growth3 Y	25.36%
Net Income Growth5 Y	51.6%
Pretax Margin	11.61%
Profit Margin	8.94%
Profit Per Employee	DKK 123,354
Profitable Years	24
ROA	4.76
Roa5y	4.35
ROCE	9.39
ROE	10.1
Roe5y	9.16
ROIC	7.2
Roic5y	6.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.71%
Cagr15y	8.24%
Cagr1y	-2.86%
Cagr3y	-5.22%
Cagr5y	-9.98%
Div CAGR10	2.26%
EPS Growth	19.15
EPS Growth Q	21.43
EPS Growth Quarters	5
EPS Growth Years	3
EPS Growth3 Y	24.84
EPS Growth5 Y	51.83
FCF Growth	3.83%
FCF Growth Q	-31.98%
FCF Growth3 Y	42.27%
FCF Growth5 Y	8.34%
OCF Growth	1.77%
OCF Growth Q	-33%
OCF Growth10 Y	5.7%
OCF Growth3 Y	31.27%
OCF Growth5 Y	9.33%
Revenue Growth	11.71x
Revenue Growth Q	14.6x
Revenue Growth Quarters	14x
Revenue Growth Years	3x
Revenue Growth3 Y	9.5x
Revenue Growth5 Y	8.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.58
Assets	DKK 11.1B
Cash	DKK 607.1M
Current Assets	DKK 2.9B
Current Liabilities	DKK 2.4B
Debt	DKK 3.6B
Debt EBITDA	DKK 3.07
Debt Equity	DKK 0.61
Debt FCF	DKK 5.11
Equity	DKK 5.9B
Interest Coverage	6.56
Liabilities	DKK 5.2B
Long Term Assets	DKK 8.2B
Long Term Liabilities	DKK 2.8B
Net Cash	DKK -3B
Net Cash By Market Cap	DKK -25.65
Net Debt EBITDA	DKK 3.06
Net Debt Equity	DKK 0.51
Net Debt FCF	DKK 4.25
Tangible Book Value	DKK -214.5M
Tangible Book Value Per Share	DKK -0.5
WACC	5.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.21
Inventory Turnover	2.28
Net Working Capital	DKK 1.1B
Quick ratio	0.63
Working Capital	DKK 502.8M
Working Capital Turnover	DKK 48.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.42%
Dividend per share	DKK 0
Last Dividend	DKK 0.15

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	7.31%
1Y total return	-2.86%
200-day SMA	31.27
3Y total return	-14.87%
50-day SMA	27.84
50-day SMA vs 200-day SMA	50under200
5Y total return	-40.87%
All Time High	57.8
All Time High Change	-52.94%
All Time High Date	2020-01-14
All Time Low	4.66
All Time Low Change	483.69%
All Time Low Date	2009-09-15
ATR	0.77
Beta	0.45
Beta1y	0.5
Beta2y	-0.09
Ch YTD	-16.31
High	27.45
High52	37.9
High52 Date	2025-12-01
High52ch	-28.23%
Low	26.8
Low52	25
Low52 Date	2026-03-30
Low52ch	8.8%
Ma50ch	-2.28%
Price vs 200-day SMA	-13.02%
RSI	46.97
RSI Monthly	42.13
RSI Weekly	39.93
Sharpe ratio	0.07x
Sortino ratio	0.26
Total Return	0.42%
Tr YTD	-16.31
Tr15y	228.12%
Tr1m	3.03%
Tr1w	1.68%
Tr3m	-9.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 813.4M
Operating Income Growth	5.06
Operating Income Growth Q	3.57
Operating Income Growth3 Y	22.72
Operating Income Growth5 Y	16.19
Operating margin	13.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	157,534,139%
Net Borrowing	-317,058,042.4
Shares Insiders	0.08%
Shares Institutions	72.77%
Shares Out	426,702,558
Shares Qo Q	1.06%
Shares Yo Y	-0.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 700.7M
Average Volume	268,674.9x
Bv Per Share	13.65
CAPEX	DKK -129.4M
Ch10y	5.43
Ch15y	212.6
Ch1m	3.03
Ch1w	1.68
Ch1y	-2.86
Ch3m	-9.33
Ch3y	-14.87
Ch5y	-40.87
Ch6m	-21.16
Change	0.18%
Change From Open	-0.55
Close	27.15
Days Gap	0.74
Depreciation Amortization	157,165,835.2
Dollar Volume	1,487,187.2
Earnings Date	2026-04-28
EBIT	DKK 813.4M
EBITDA	DKK 974M
EPS	DKK 1.31
F Score	6
FCF	DKK 700.7M
FCF EV Yield	4.79x
FCF Per Share	DKK 1.64
Financing CF	-429,489,138
Fiscal Year End	December
Founded	1,971
Goodwill	5,251,189,024.4
Graham Number	20.05527
Graham Upside	-26.27
Income Tax	DKK 162.8M
Investing CF	-401,447,270
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	DKK 32.52
Lynch Upside	19.57
Ma150	31.14
Ma150ch	-12.66%
Ma20	27.57
Ma20ch	-1.32%
Net CF	12,238,337
Next Earnings Date	2026-07-21
Open	27.35
P FCF Ratio	16.56
P OCF Ratio	13.98
Position In Range	61.54
Ppne	1,517,428,910.8
Price Date	2026-05-08
Price EBITDA	DKK 11.92
Relative Volume	0.21x
Revenue	6,211,850,547x
Tax By Revenue	2.62x
Tax Rate	22.58%
Tr6m	-21.16%
Volume	54,676
Z Score	3.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/EMBLA pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/EMBLA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/EMBLA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+72.8%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

CPH/EMBLA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.0

Neutral momentum band

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/EMBLA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/EMBLA stock rating?

cph/EMBLA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/EMBLA analysis?

The full report lives at /stocks/cph/EMBLA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/EMBLA?

The latest report frames cph/EMBLA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/EMBLA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.